Literature DB >> 12762561

Ketamine associated psychedelic effects and dependence.

D K Lim1.   

Abstract

Ketamine, a dissociative anaesthetic in use since 1970, produces prominent psychoactive effects in humans. Its non-medical use has raised concerns in many countries, including Singapore. This paper narrates the psychedelic and psychotic effects of ketamine in two ketamine dependent patients who have presented to the psychiatric service. These effects were dose-related and comprised multimodal hallucinatory experiences, a sense of slowing, paranoid ideation and enhancement of sexual, musical and sensory enjoyment. In both ketamine users the psychotic symptoms resolved quickly with symptom-targeted treatment. However, breaking the ongoing addiction cycle seemed more difficult. The neuro-pharmacological mechanisms of these phenomena are largely due to its complex multi-receptors actions, notably through the excitatory amino acids through mainly the N-methy-D-aspartate (NMDA) receptors. The detection of ketamine abuse requires a high index of suspicion and needs to be considered when there is an acute presentation with multi-modal hallucinations and psychosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12762561

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  12 in total

1.  Individual and peer factors associated with ketamine use among adolescents in Taiwan.

Authors:  Kun-Hua Lee; Yi-Chun Yeh; Pin-Chen Yang; Huang-Chi Lin; Peng-Wei Wang; Tai-Ling Liu; Cheng-Fang Yen
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-06-22       Impact factor: 4.785

2.  A methoxydiphenidine-impaired driver.

Authors:  Nicole Stachel; Andrea Jacobsen-Bauer; Gisela Skopp
Journal:  Int J Legal Med       Date:  2015-10-19       Impact factor: 2.686

Review 3.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

4.  Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.

Authors:  Nolan R Williams; Boris D Heifets; Christine Blasey; Keith Sudheimer; Jaspreet Pannu; Heather Pankow; Jessica Hawkins; Justin Birnbaum; David M Lyons; Carolyn I Rodriguez; Alan F Schatzberg
Journal:  Am J Psychiatry       Date:  2018-08-29       Impact factor: 18.112

5.  Sit Down to Float: The Cultural Meaning of Ketamine Use in Hong Kong.

Authors:  Karen Joe-Laidler; Geoffrey Hunt
Journal:  Addict Res Theory       Date:  2008-06-01

6.  Ketamine-Induced Hallucinations.

Authors:  Albert R Powers; Mark G Gancsos; Emily S Finn; Peter T Morgan; Philip R Corlett
Journal:  Psychopathology       Date:  2015-09-12       Impact factor: 1.944

Review 7.  Legal highs: staying on top of the flood of novel psychoactive substances.

Authors:  David Baumeister; Luis M Tojo; Derek K Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2015-04

Review 8.  Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development.

Authors:  Jennifer Leigh Green; Wagner Ferreira Dos Santos; Andréia Cristina Karklin Fontana
Journal:  Biochem Pharmacol       Date:  2021-09-24       Impact factor: 5.858

Review 9.  To use or not to use: an update on licit and illicit ketamine use.

Authors:  Jih-Heng Li; Balasingam Vicknasingam; Yuet-Wah Cheung; Wang Zhou; Adhi Wibowo Nurhidayat; Don C Des Jarlais; Richard Schottenfeld
Journal:  Subst Abuse Rehabil       Date:  2011-03-16

10.  Gender differences in subjective discontinuation symptoms associated with ketamine use.

Authors:  Wen-Yin Chen; Ming-Chyi Huang; Shih-Ku Lin
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.